Evidence map›Paper›PMID 32804281›Full record

ArticleJournal of neurology2021

Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.

Jacob D Jones, Carmen Uribe, Joseph Bunch, Kelsey R Thomas

Open access · greenAbstract read
In one paragraph

Article in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jacob D JonesDepartment of Psychology, Center on Aging, California State University San Bernardino, 5500 University Parkway, San Bernardino, CA, 92407-2318, USA. Jacob.jones@csusb.edu.ORCID http://orcid.org/0000-0003-3544-7294
Carmen UribeDepartment of Psychology, Center on Aging, California State University San Bernardino, 5500 University Parkway, San Bernardino, CA, 92407-2318, USA.
Joseph BunchDepartment of Psychology, Center on Aging, California State University San Bernardino, 5500 University Parkway, San Bernardino, CA, 92407-2318, USA.
Kelsey R ThomasVeteran Affairs San Diego Healthcare System, San Diego, CA, USA.
California State University, San Bernardino · USUniversity of California San Diego · US

Funding

CSU San Bernardino Minority Access to Research CareersT34GM083883 · NIGMS · CALIFORNIA STATE UNIV SAN BERNARDINO · PI MCDOUGALL, SANDERS · 2009 to 2019
$3.0M
U-RISE at CSUSBT34GM136467 · NIGMS · CALIFORNIA STATE UNIV SAN BERNARDINO · PI Leslie Renee Amodeo, Jacob D Jones · 2020 to 2026
$2.6M
Identifying best methods for the detection of subtle cognitive declineR03AG070435 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI THOMAS, KELSEY R · 2021 to 2022
$316k
Impact of Diabetes on Cognitive and Perfusion Inefficiencies in Preclinical ADIK2CX001865 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI Kelsey R Thomas · 2020 to 2026
–
CSRD VA IK2 CX001865NIA NIH HHS R03 AG070435NIGMS NIH HHS T34 GM083883NIGMS NIH HHS T34 GM136467NIH HHS T34GM083883
6 · The paper itself

Abstract

objectiveCognitive impairment is prevalent among individuals with Parkinson's disease (PD). Effort has been made to identify individuals at risk for cognitive decline and dementia. Objectively-defined subtle cognitive decline (Obj-SCD) is a novel classification that may identify individuals at risk for cognitive decline prior to a diagnosis of mild cognitive impairment (MCI). We examined the utility of Obj-SCD criteria to predict future cognitive decline and difficulties with activities of daily living (ADLs) among individuals with PD.

methodThe sample included 483 individuals newly diagnosed with PD. Participants were followed for a five-year span with yearly visits where they completed neuropsychological tests. Participants were categorized as cognitively normal (CN), the newly proposed Obj-SCD, PD-MCI or Parkinson's disease dementia (PDD). Analyses determined if utilization of Obj-SCD criteria predicted subsequent cognitive impairment and difficulties with ADLs.

resultsAt baseline, 372 (77%) participants were classified as CN, 40 (8.3%) classified as Obj-SCD, and 71 (14.7%) classified as PD-MCI. Analyses revealed that relative to the CN group, participants classified as Obj-SCD at baseline, were more likely to develop PD-MCI or PDD within 5 years (odds ratio 2.413; 95% confidence interval 1.215-4.792). Furthermore, the Obj-SCD represented an intermediate level of impairment, relative to the CN and PD-MCI groups, on an independent measure of cognition (Montreal Cognitive Assessment) and ADL.

conclusionsFindings provide evidence that Obj-SCD criteria can identify individuals at risk for cognitive decline and impairments in ADL. Obj-SCD criteria may identify individuals at risk for cognitive impairment who are not detected by PD-MCI criteria.

Indexed as

Cognitive DysfunctionParkinson DiseaseActivities of Daily LivingCognitionHumansNeuropsychological TestsCognitive dysfunctionDementiaEarly detectionMild cognitive impairmentNeuropsychologyParkinson’s disease

Identifiers

PMID32804281
PMCPMC7855683
OpenAlexW3058823369

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.